Nine large pharma companies have reached agreements with the Trump administration to lower certain drug prices in the U.S. | ...

The companies were the latest to agree to sell drugs to Medicaid and directly to consumers at discounted prices. President ...

The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models.

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

US President Donald Trump announced on Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

Dow Jones stock Merck and eight other bellwether pharma companies struck drug-pricing agreements with the Trump ...

AI spending isn’t expected to slow in 2026. In a research note shared with TheStreet, Goldman Sachs predicted that ...

President Donald Trump announced Friday that nine additional pharmaceutical companies joined its most-favored-nation pricing ...

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.

S&P 500 upside continues: Ross stays bullish from both top-down and bottom-up perspectives, arguing that falling inflation, yields and energy prices, combined with steeper curves and tighter spreads, ...